Improving the luteal phase after ovarian stimulation: Reviewing new options

Reproductive BioMedicine Online

Volumn 28, Issue 5, 2014, Pages 552-559

  Yding Andersen, C ^a,b   Vilbour Andersen, K ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b ARTs Biologics   (Denmark)

Author keywords

corpus luteum function; early pregnancy loss; GnRH agonist trigger; low dose hCG; luteal phase; progesterone

Indexed keywords

CHORIONIC GONADOTROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; NITRIC OXIDE; PROGESTERONE; RECOMBINANT LUTEINIZING HORMONE;

ABORTION; BLOOD FLOW; CONCEPTION; CORPUS LUTEUM; DEMOGRAPHY; EMBRYO TRANSFER; ENDOMETRIUM; FIRST TRIMESTER PREGNANCY; FOLLICULAR PHASE; HALF LIFE TIME; HUMAN; IMPLANTATION; INCIDENCE; INTRACYTOPLASMIC SPERM INJECTION; INTRAUTERINE INSEMINATION; LIVE BIRTH; LUTEAL CELL; LUTEAL PHASE; MYOMETRIUM; NEGATIVE FEEDBACK; NONHUMAN; OOCYTE RETRIEVAL; OVARIAN STIMULATION; OVARY FUNCTION; OVARY HYPERSTIMULATION; OVULATION; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PREGNANCY TEST; PROGESTERONE BLOOD LEVEL; PROGESTERONE RELEASE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SPONTANEOUS ABORTION; SUPPLEMENTATION; TH2 CELL; BLOOD; DRUG EFFECTS; FEMALE; FERTILIZATION IN VITRO; OVARIAN HYPERSTIMULATION SYNDROME; PROCEDURES;

CHORIONIC GONADOTROPIN; FEMALE; FERTILIZATION IN VITRO; HUMANS; LUTEAL PHASE; OOCYTE RETRIEVAL; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PREGNANCY; PROGESTERONE;

EID: 84899929832     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2014.01.012     Document Type: Review

References (48)

1. B. Acevedo, J.L. Gomez-Palomares, E. Ricciarelli, and E.R. Hernández Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates Fertil. Steril. 86 2006 1682 1687
2. B. Alsbjerg, N.P. Polyzos, H.O. Elbaek, B.B. Povlsen, C.Y. Andersen, and P. Humaidan Increasing vaginal progesterone gel supplementation after frozen-thawed embryo transfer significantly increases the delivery rate Reprod. Biomed. Online 26 2013 133 137
3. C.Y. Andersen, L.G. Westergaard, Y. Figenschau, K. Bertheussen, and F. Forsdahl Endocrine composition of follicular fluid comparing human chorionic gonadotrophin to a gonadotrophin-releasing hormone agonist for ovulation induction Hum. Reprod. 8 1993 840 843
4. J.-C. Arce, A. Balen, P. Platteau, G. Pettersson, and A.N. Andersen Mid-luteal progesterone concentrations are associated with live birth rates during ovulation induction Reprod. Biomed. Online 22 2011 449 456
5. D.D. Baird, A.J. Wilcox, C.R. Weinberg, F. Kamel, D.R. McConnaughey, P.I. Musey, and D.C. Collins Preimplantation hormonal differences between the conception and non-conception menstrual cycles of 32 normal women Hum. Reprod. 12 1997 2607 2613
6. J. Balasch, M. Creus, F. Fábregues, F. Carmona, R. Casamitjana, J. Peñarrubia, F. Rivera, and J.A. Vanrell Hormonal profiles in successful and unsuccessful implantation in IVF-ET after combined GnRH agonist/gonadotropin treatment for superovulation and hCG luteal support Gynecol. Endocrinol. 9 1995 51 58
7. D. Bodri, J.J. Guillén, A. Galindo, D. Mataró, A. Pujol, and O. Coll Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study Fertil. Steril. 91 2009 365 371
8. R. Druckmann, and M.A. Druckmann Progesterone and the immunology of pregnancy J. Steroid Biochem. Mol. Biol. 97 2005 389 396
9. A. Ellenbogen, Y. Gidoni, M. Michaeli, N. Rotfarb, and S. Ballas Mid-luteal serum progesterone and estradiol levels as predictors of pregnancy in IVF-ET cycles: may increasing the dosage of progesterone supplementation improve the outcome? Fertil. Steril. 82 2004 S205 (P201)
10. B.C. Fauser, D. De Jong, F. Loivennes, H. Wramsby, C. Tay, J. Itskovitz-Eldor, and H.G. Van Hooren Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist Ganirelix during ovarian hyperstimulation for in vitro fertilization J. Clin. Endocrinol. Metab. 87 2002 709 715
11. B.C.J.M. Fauser, B.M.J.L. Mannaerts, P. Devroey, A. Leader, I. Boime, and D.T. Baird Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency Hum. Reprod. Update 15 2009 309 321
12. R.E. Felberbaum, C. Albano, M. Ludwig, H. Riethmüller-Winzen, M. Grigat, P. Devroey, and K. Diedrich Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study Hum. Reprod. 15 2000 1015 1020
13. Y. Gonen, H. Balakier, W. Powell, and R.F. Casper Use of GnRH agonist to trigger follicular maturation for in vitro fertilization J. Clin. Endocrinol. Metab. 71 1990 918 922
14. G. Griesinger, E.M. Kolibianakis, E.G. Papanikolaou, K. Diedrich, A. Van Steirteghem, P. Devroey, H. Ejdrup Bredkjaer, and P. Humaidan Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles Fertil. Steril. 88 2007 616 621
15. N.P. Groome, P.J. Illingworth, M. O'Brien, R. Pai, F.E. Rodger, J.P. Mather, and A. McNeilly Measurement of dimeric inhibin B throughout the human menstrual cycle J. Clin. Endocrinol. Metab. 81 1996 1401 1407
16. M.G. Hammond, and L.M. Talbert Clomiphene citrate therapy of infertile women with low luteal phase progesterone levels Obstet. Gynecol. 59 1982 275 279
17. N.C. Hill, M. Selinger, J. Ferguson, A. López Bernal, and I.Z. Mackenzie The physiologicaland clinical effects of progesterone inhibition with mifepristone (RU 486) in the second trimester Br. J. Obstet. Gynaecol. 97 1990 487 492
18. M.G. Hull, P.E. Savage, D.R. Bromham, A.A. Ismail, and A.F. Morris The value of a single serum progesterone measurement in the midluteal phase as a criterion of a potentially fertile cycle ('ovulation') derived form treated and untreated conception cycles Fertil. Steril. 37 1982 355 360
19. P. Humaidan, H.E. Bredkjaer, L. Bungum, M. Bungum, M.L. Grøndahl, L. Westergaard, and C.Y. Andersen GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study Hum. Reprod. 20 2005 1213 1220
20. P. Humaidan, L. Bungum, M. Bungum, and C. Yding Andersen Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study Reprod. Biomed. Online 13 2006 173 178
21. P. Humaidan, H. Ejdrup Bredkjaer, L.G. Westergaard, and C. Yding Andersen 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study Fertil. Steril. 93 2010 847 854
22. P. Humaidan, B. Alsbjerg, A.L. Mikkelsen, H. Elbaek, K. Erb, E.G. Papanikolaou, and C. Yding Andersen GnRHa trigger and luteal phase hCG support according to ovarian response to stimulation in IVF patients - a randomized controlled multi-centre study Hum. Reprod. 28 2013 2511 2521
23. J.S. Hutchison, and A.J. Zeleznik The corpus luteum of the primate menstrual cycle is capable of recovering from a transient withdrawal of pituitary gonadotropin support Endocrinology 117 1985 1043 1049
24. J. Itskovitz, R. Boldes, J. Levron, Y. Erlik, L. Kahana, and J.M. Brandes Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist Fertil. Steril. 56 1991 213 220
25. E.M. Kolibianakis, A. Schultze-Mosgau, A. Schroer, A. van Steirteghem, P. Devroey, K. Diedrich, and G. Griesinger A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists Hum. Reprod. 20 2005 2887 2892
26. N. Laufer, D. Navot, and J.G. Schenker The pattern of luteal phase plasma progesterone and estradiol in fertile cycles Am. J. Obstet. Gynecol. 143 1982 808 813
27. H. Levine, and N. Watson Comparison of the pharmacokinetics of Crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women Fertil. Steril. 73 2000 516 521
28. H.C. Liu, E. Pyrgiotis, O. Davis, and Z. Rosenwaks Active corpus luteum function at pre-, peri- and postimplantation is essential for a viable pregnancy Early Pregnancy Biol. Med. 1 1995 281 287
29. I.E. Messinis Ovarian feedback, mechanism of action and possible clinical implications Hum. Reprod. Update 5 2006 557 571
30. I.E. Messinis, T. Bergh, and L. Wide The importance of human chorionic gonadotropin support of the corpus luteum during human gonadotropin therapy in women with anovulatory infertility Fertil. Steril. 50 1988 31 35
31. M.F. Mitwally, M.P. Diamond, and M. Abuzeid Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization-embryo transfer Fertil. Steril. 93 2010 554 569
32. M.H. Mochtar, H.V. Hogerzeil, and B.W. Mol Progesterone alone versus progesterone combined with HCG as luteal support in GnRHa/HMG induced IVF cycles: a randomized clinical trial Hum. Reprod. 11 1996 1602 1605
33. M.W. Molo, R.G. Rawlins, Z. Binor, M. Kelly, and E. Radwanska Luteal phase estradiol and pregnancy outcome in gonadotropin releasing hormone agonist/human menopausal gonadotropin-treated gamete intrafallopian transfer cycles J. Reprod. Med. 40 1995 418 422
34. E.G. Papanikolaou, W. Verpoest, H. Fatemi, B. Tarlatzis, P. Devroey, and H. Tournaye A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study Fertil. Steril. 95 2011 1174 1177
35. E. Radwanska, P. Smith, and J. Hammond Correlation between preovulatory serum estradiol and midluteal progesterone levels during induction of ovulation with Clomid and HCG J. Reprod. Med. 24 1980 79 82
36. H.N. Sallam, A. Sallam, F. Ezzeldin, A.F. Agamia, and A. Abou-Ali Reference values for the midluteal plasma progesterone concentration: evidence from human menopausal gonadotropin-stimulated pregnancy cycles Fertil. Steril. 71 1999 711 714
37. B.S. Shapiro, S.T. Daneshmand, F.C. Garner, M. Aguirre, C. Hudson, and S. Thomas Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfer in normal responders Fertil. Steril. 96 2011 344 348
38. B.S. Shapiro, S.T. Daneshmand, H. Restrepo, and F.C. Garner Serum HCG measured in the peri-implantation period predicts IVF cycle outcomes Reprod. Biomed. Online 25 2012 248 253
39. Sherbahn, Richard. < http://www.advancedfertility.com/earlypre.htm > (accessed Sep. 9th 2013).
40. T. Simoncini, A. Caruso, and M.S. Giretti Effects of dydrogesterone and of its stable metabolite, 20-alpha-dihydrodydrogesterone, on nitric oxide synthesis in human endothelial cells Fertil. Steril. 86 2006 1235 1242
41. S.M. Sladek, R.R. Magness, and K.P. Conrad Nitric oxide and pregnancy Am. J. Physiol. 272 1997 R441 R463
42. J. Szekeres-Bartho, J.R. Wilczynski, P. Basta, and J. Kalinka Role of progesterone and progestin therapy in threatened abortion and preterm labour Front. Biosci. 13 2008 1981 1990
43. L.L. Thuesen, A. Loft, A.N. Egeberg, J. Smitz, J.H. Petersen, and A.N. Andersen A randomized controlled dose-response pilot study of addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization Hum. Reprod. 27 2012 3074 3084
44. I. Trinchard-Lugan, A. Khan, H.C. Porchet, and A. Munafo Pharmacokinetics and pharmacodynamics of recombinant human chorionic gonadotrophin in healthy male and female volunteers Reprod. Biomed. Online 4 2002 106 115
45. A.C. Van Steirteghem, J. Smitz, M. Camus, L. Van Waesberghe, J. Deschacht, I. Khan, C. Staessen, A. Wisanto, C. Bourgain, and P. Devroey The luteal phase after in-vitro fertilization and related procedures Hum. Reprod. 3 1998 161 164
46. J.L. Yovich, J.D. Stanger, J.M. Yovich, A.I. Tuvik, and S.R. Turner Hormonal profiles in the follicular phase, luteal phase and first trimester of pregnancies arising from in-vitro fertilization Br. J. Obstet. Gynaecol. 92 1985 374 384
47. J.L. Yovich, S.C. McColm, J.M. Yovich, and P.L. Matson Early luteal serum progesterone concentrations are higher in pregnancy cycles Fertil. Steril. 44 1985 185 189
48. J.L. Yovich, D.L. Willcox, J.G. Grudzinskas, and A.E. Bolton The prognostic value of HCG, PAPP-A, oestradiol-17 beta and progesterone in early human pregnancy Aust. N. Z. J. Obstet. Gynaecol. 26 1986 59 64